Skip to content

ADMA Biologics ADMA Change in AR

Change in AR at other companies

Zymeworks logo
ZymeworksZYME
$36K+100%
Quest Diagnostics logo
Quest DiagnosticsDGX
$180M+78.2%
AbbVie logo
AbbVieABBV
-$87M-106%
Amgen logo
AmgenAMGN
-$413M-132%
TG Therapeutics logo
TG TherapeuticsTGTX
$86.42M+41.8%
Abbott logo
AbbottABT
$42M-84.0%

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's change in AR?
ADMA Biologics (ADMA) reported change in AR of -$22.57M in Q1 2026.
How has ADMA Biologics's change in AR changed year-over-year?
ADMA Biologics's change in AR decreased by 145.7% year-over-year, from $49.41M to -$22.57M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.